Verrica Pharmaceuticals (VRCA) Other Operating Expenses (2020 - 2026)
Verrica Pharmaceuticals (VRCA) posted quarterly Other Operating Expenses of $889000.0 for Q1 2026, up 103.43% year-over-year from $437000.0 in Q1 2025, and down 46.02% quarter-over-quarter from $1.6 million in Q4 2025.
Verrica Pharmaceuticals (VRCA) Other Operating Expenses (2020 - 2026) Analysis & Trends
Verrica Pharmaceuticals' Other Operating Expenses history runs 7 years deep, the most recent figure standing at $889000.0 for Q1 2026.
- In Q1 2026, Other Operating Expenses rose 103.43% year-over-year to $889000.0; the TTM figure through Mar 2026 stood at $4.1 million (up 95.05% YoY), while the FY2025 annual figure was -$246000.0, down 146.0% from the prior year.
- Other Operating Expenses for Q1 2026 stood at $889000.0, down from $1.6 million in the prior quarter.
- The five-year high for Other Operating Expenses was $2.8 million in Q4 2023, with the low at $62000.0 in Q4 2022.
- The 5-year median for Other Operating Expenses is $437000.0 (2025), against an average of $671000.0.
- The sharpest annual moves came in 2022 and 2023: Other Operating Expenses plunged 99.55% in 2022, then soared 4430.65% in 2023.
- Verrica Pharmaceuticals' Other Operating Expenses stood at $62000.0 in 2022, then jumped by 4430.65% to $2.8 million in 2023, then tumbled by 74.8% to $708000.0 in 2024, then surged by 132.63% to $1.6 million in 2025, then slumped by 46.02% to $889000.0 in 2026.
- Business Quant data shows VRCA's Other Operating Expenses at $889000.0 in Q1 2026, $1.6 million in Q4 2025, and $1.1 million in Q3 2025.
Powered by 
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) |
|---|---|---|---|---|
| 1 | Vertex Pharmaceuticals | 139.13 Bn | 131.28 Bn | 2.84 Bn |
| 2 | Regeneron Pharmaceuticals | 85.77 Bn | 77.77 Bn | 3.93 Bn |
| 3 | Argenx Se | 64.64 Bn | 59.46 Bn | 1.37 Bn |
| 4 | Moderna | 58.29 Bn | 53.16 Bn | 52.00 Mn |
| 5 | BeOne Medicines | 41.92 Bn | 36.82 Bn | 1.53 Bn |
| 6 | Alnylam Pharmaceuticals | 31.58 Bn | 28.28 Bn | 992.69 Mn |
| 7 | BioNTech SE | 28.12 Bn | 9.73 Bn | 668.28 Mn |
| 8 | Insmed | 27.39 Bn | 26.22 Bn | 358.27 Mn |
| 9 | Royalty Pharma | 27.27 Bn | 26.43 Bn | - |
| 10 | Verrica Pharmaceuticals | 102.80 Mn | 91.60 Mn | - |
Historic Data
Download Data| Date | Value |
|---|---|
| Jun 30, 2026 | -1.70 Mn |
| Mar 31, 2026 | 889,000.00 |
| Dec 31, 2025 | 1.65 Mn |
| Sep 30, 2025 | 1.11 Mn |
| Jun 30, 2025 | 494,000.00 |
| Mar 31, 2025 | 437,000.00 |
| Dec 31, 2024 | 708,000.00 |
| Sep 30, 2024 | 435,000.00 |
| Jun 30, 2024 | 542,000.00 |
| Mar 31, 2024 | 1.14 Mn |
| Dec 31, 2023 | 2.81 Mn |
| Sep 30, 2023 | 270,000.00 |
| Jun 30, 2023 | 136,000.00 |
| Mar 31, 2023 | 68,000.00 |
| Dec 31, 2022 | 62,000.00 |
| Sep 30, 2022 | 166,000.00 |
| Jun 30, 2022 | 219,000.00 |
| Mar 31, 2022 | 278,000.00 |
| Dec 31, 2021 | 13.63 Mn |
| Dec 31, 2020 | 15.37 Mn |